Previous 10 | Next 10 |
--News Direct-- Our recent survey conducted with The Harris Poll and Depression and Bipolar Support Alliance – National Headquarters found that sleep quality is a top concern among the adults with bipolar I disorder who participated in the survey. This Sleep Awarene...
Clinical-stage biotech Nektar Therapeutics (NKTR -55.0%) continues to trade sharply lower on Monday after the company announced its lead candidate bempegaldesleukin failed to meet the main goals in a late-stage study in melanoma in combination with Opdivo from Bristol Myers (NYSE:BMY). I...
Clinical-stage biotech, Nektar Therapeutics (NKTR -2.7%) has lost more than 53% in the pre-market Monday after the company and Bristol Myers Squibb (NYSE:BMY) announced a major setback for its lead immuno-oncology candidate bempegaldesleukin in a late-stage trial for melanoma. The P...
Palm Beach, FL –– March 8, 2022 – FinancialNewsMedia.com News Commentary – According to a report from Grand View Research “High unmet medical needs and government initiatives to reduce the psychiatric and neurological disorders are driving the ...
--News Direct-- Our recent survey conducted with Harris Poll and Depression and Bipolar Support Alliance found that a vast majority of respondents who live with bipolar I disorder experienced medication side effects that negatively impacted their daily lives. Learn more . ...
Alkermes to Present Data on Nemvaleukin Alfa at the Society of Gynecologic Oncology 2022 Annual Meeting on Women's Cancer - New Ovarian Cancer Data From ARTISTRY-1 Clinical Trial to be Featured in Oral Plenary Session - PR Newswire DUBLIN , March 1, 2022 /PRN...
PBE is neither suitable for income seekers, nor for long term investors. Despite being a Genomic revolution fund, it lacks focus, and invested heavily on large cap diverse biotechnology companies. Better biotechnology ETFs of similar nature are available in the market. For f...
FBT is a passive biotechnology ETF, which doesn’t pay any dividend. Baring the past one year, FBT’s price return has outperformed the S&P 500. Effective portfolio rebalancing may determine its future growth. For further details see: FBT: A Long Term Hol...
--News Direct-- Our recent survey conducted with Harris Poll and Depression and Bipolar Support Alliance found that many individuals with Bipolar 1 disorder felt that finding the right treatment can be a long and difficult process. Learn more . About Alkermes Alkermes pl...
--News Direct-- #BlackHistoryMonth represents an opportunity to highlight the disparities within the Black community when it comes to mental health. According to a 2018 survey, 50% of Black adults with serious mental illness did not receive treatment. We encourage foll...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...